↓ Skip to main content

Bile Acids and Their Receptors

Overview of attention for book
Cover of 'Bile Acids and Their Receptors'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 225 Signaling from Intestine to the Host: How Bile Acids Regulate Intestinal and Liver Immunity.
  3. Altmetric Badge
    Chapter 226 Chenodeoxycholic Acid: An Update on Its Therapeutic Applications
  4. Altmetric Badge
    Chapter 227 Obeticholic Acid: An Update of Its Pharmacological Activities in Liver Disorders
  5. Altmetric Badge
    Chapter 228 Pharmacologic Modulation of Bile Acid-FXR-FGF15/FGF19 Pathway for the Treatment of Nonalcoholic Steatohepatitis
  6. Altmetric Badge
    Chapter 229 Targeting Bile Acid-Activated Receptors in Bariatric Surgery
  7. Altmetric Badge
    Chapter 230 Bile Acid-Activated Receptors: GPBAR1 (TGR5) and Other G Protein-Coupled Receptors
  8. Altmetric Badge
    Chapter 231 Targeting FXR in Cholestasis
  9. Altmetric Badge
    Chapter 232 Nonsteroidal FXR Ligands: Current Status and Clinical Applications
  10. Altmetric Badge
    Chapter 233 Potential of Intestine-Selective FXR Modulation for Treatment of Metabolic Disease
  11. Altmetric Badge
    Chapter 234 Structural Insight into the Binding Mode of FXR and GPBAR1 Modulators
  12. Altmetric Badge
    Chapter 235 The Enterokine Fibroblast Growth Factor 15/19 in Bile Acid Metabolism
  13. Altmetric Badge
    Chapter 236 Bile Acid-Activated Receptors: A Review on FXR and Other Nuclear Receptors
  14. Altmetric Badge
    Chapter 237 Chemistry and Pharmacology of GPBAR1 and FXR Selective Agonists, Dual Agonists, and Antagonists
  15. Altmetric Badge
    Chapter 238 The Pharmacology of Bile Acids and Their Receptors
  16. Altmetric Badge
    Chapter 241 UDCA, NorUDCA, and TUDCA in Liver Diseases: A Review of Their Mechanisms of Action and Clinical Applications
Attention for Chapter 225: Signaling from Intestine to the Host: How Bile Acids Regulate Intestinal and Liver Immunity.
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
3 X users

Citations

dimensions_citation
12 Dimensions

Readers on

mendeley
29 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Signaling from Intestine to the Host: How Bile Acids Regulate Intestinal and Liver Immunity.
Chapter number 225
Book title
Bile Acids and Their Receptors
Published in
Handbook of experimental pharmacology, May 2019
DOI 10.1007/164_2019_225
Pubmed ID
Book ISBNs
978-3-03-022004-4, 978-3-03-022005-1
Authors

Biagioli, Michele, Carino, Adriana, Michele Biagioli, Adriana Carino

Abstract

Primary bile acids (BAs) are generated in the liver as the end products of cholesterol catabolism; they are then conjugated and accumulated in the gallbladder. After a meal ingestion, BAs are reversed into the duodenum to facilitate the lipid absorption. At the intestinal level, the 95% of BAs are reabsorbed and redirected into enterohepatic circulation; indeed only a small amount of them are then subjected to chemical modifications by the intestinal microbiota, which plays a very important role in the generation of secondary bile acids and in regulating host's metabolism and activity of the immune system. Behind their role in nutrients absorption, bile acids act as signaling molecules, activating several receptors, known as bile acid-activated receptors (BARs), including the farnesoid-X-receptor (FXR) and the G protein-coupled bile acid receptor 1 (GPBAR1 or Takeda G-protein receptor 5). Both receptors appear to contribute to maintain the tolerogenic state of the liver and intestine immunity. In particular, FXR and GPBAR1 are highly expressed in cells of innate immunity including intestinal and liver macrophages, dendritic cells, and natural killer T cells. In this chapter, we provide an overview on mechanisms through which FXR and GPBAR1 modulate the signaling between microbiota and intestinal and liver innate immune system. This overview could help to explain beneficial effects exerted by GPBAR1 and FXR agonists in the treatment of metabolic and immuno-mediated diseases.

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 29 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 29 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 7 24%
Student > Bachelor 5 17%
Student > Ph. D. Student 5 17%
Professor 2 7%
Other 1 3%
Other 0 0%
Unknown 9 31%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 7 24%
Agricultural and Biological Sciences 3 10%
Pharmacology, Toxicology and Pharmaceutical Science 2 7%
Medicine and Dentistry 2 7%
Nursing and Health Professions 2 7%
Other 2 7%
Unknown 11 38%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 September 2019.
All research outputs
#18,021,930
of 23,148,322 outputs
Outputs from Handbook of experimental pharmacology
#489
of 650 outputs
Outputs of similar age
#245,871
of 350,389 outputs
Outputs of similar age from Handbook of experimental pharmacology
#4
of 6 outputs
Altmetric has tracked 23,148,322 research outputs across all sources so far. This one is in the 19th percentile – i.e., 19% of other outputs scored the same or lower than it.
So far Altmetric has tracked 650 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.4. This one is in the 22nd percentile – i.e., 22% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 350,389 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 25th percentile – i.e., 25% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 6 others from the same source and published within six weeks on either side of this one. This one has scored higher than 2 of them.